NeuroPace (NPCE) Non-Current Debt (2020 - 2026)
NeuroPace's quarterly Non-Current Debt came in at $59.0 million in Q1 2026, down 1.28% year-on-year from $59.8 million in Q1 2025, and little changed quarter-over-quarter from $58.9 million in Q4 2025.
NeuroPace has reported Non-Current Debt for 7 years, with the latest figure at $59.0 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Debt fell 1.28% year-over-year to $59.0 million; the trailing twelve-month figure through Mar 2026 stood at $59.0 million (down 1.28% YoY), and the FY2025 full-year result was $58.9 million, down 1.08% from the prior year.
- Non-Current Debt for Q1 2026 stood at $59.0 million, roughly flat from $58.9 million in the prior quarter.
- The five-year high for Non-Current Debt was $59.8 million in Q1 2025, with the low at $50.1 million in Q1 2022.
- Average Non-Current Debt over 5 years is $56.4 million, with a median of $58.0 million recorded in 2024.
- Year-over-year, Non-Current Debt advanced 7.76% in 2024 and declined 1.28% in 2026.
- Tracing NPCE's Non-Current Debt over 5 years: stood at $52.9 million in 2022, then increased by 7.64% to $57.0 million in 2023, then increased by 4.51% to $59.5 million in 2024, then declined by 1.08% to $58.9 million in 2025, then grew by 0.23% to $59.0 million in 2026.
- The last three Non-Current Debt figures came in at $59.0 million (Q1 2026), $58.9 million (Q4 2025), and $58.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 27.88 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.81 Bn |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | 59.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.02 Mn |
| Mar 31, 2026 | 59.02 Mn |
| Dec 31, 2025 | 58.88 Mn |
| Dec 31, 2025 | 58.88 Mn |
| Sep 30, 2025 | 58.75 Mn |
| Sep 30, 2025 | 58.75 Mn |
| Jun 30, 2025 | 58.62 Mn |
| Jun 30, 2025 | 58.62 Mn |
| Mar 31, 2025 | 59.79 Mn |
| Mar 31, 2025 | 59.79 Mn |
| Dec 31, 2024 | 59.53 Mn |
| Dec 31, 2024 | 59.53 Mn |
| Sep 30, 2024 | 59.27 Mn |
| Sep 30, 2024 | 59.27 Mn |
| Jun 30, 2024 | 59.02 Mn |
| Jun 30, 2024 | 59.02 Mn |
| Mar 31, 2024 | 58.04 Mn |
| Mar 31, 2024 | 58.04 Mn |
| Dec 31, 2023 | 56.95 Mn |
| Dec 31, 2023 | 56.95 Mn |
| Sep 30, 2023 | 55.89 Mn |
| Sep 30, 2023 | 55.89 Mn |
| Jun 30, 2023 | 54.85 Mn |
| Jun 30, 2023 | 54.85 Mn |
| Mar 31, 2023 | 53.86 Mn |
| Mar 31, 2023 | 53.86 Mn |
| Dec 31, 2022 | 52.91 Mn |
| Dec 31, 2022 | 52.91 Mn |
| Sep 30, 2022 | 51.95 Mn |
| Sep 30, 2022 | 51.95 Mn |
| Jun 30, 2022 | 51.02 Mn |
| Jun 30, 2022 | 51.02 Mn |
| Mar 31, 2022 | 50.12 Mn |
| Mar 31, 2022 | 50.12 Mn |
| Dec 31, 2021 | 49.85 Mn |
| Dec 31, 2021 | 49.85 Mn |
| Sep 30, 2021 | 49.58 Mn |
| Sep 30, 2021 | 49.58 Mn |
| Jun 30, 2021 | 49.35 Mn |
| Jun 30, 2021 | 49.35 Mn |
| Mar 31, 2021 | 49.56 Mn |
| Mar 31, 2021 | 49.56 Mn |
| Dec 31, 2020 | 50.82 Mn |
| Dec 31, 2020 | 50.82 Mn |